Evidence map›Paper›PMID 25108145›Full record

ArticleAmerican journal of obstetrics and gynecology2015

Human trophoblasts confer resistance to viruses implicated in perinatal infection.

Avraham Bayer, Elizabeth Delorme-Axford, Christie Sleigher, Teryl K Frey, Derek W Trobaugh, William B Klimstra, Lori A Emert-Sedlak, Thomas E Smithgall, Paul R Kinchington, Stephen Vadia and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of obstetrics and gynecology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 113 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Avraham BayerMagee-Womens Research Institute, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Elizabeth Delorme-AxfordDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15219, USA.
Christie SleigherGeorgia State University, Biology Department, Atlanta, GA, 30303, USA.
Teryl K FreyGeorgia State University, Biology Department, Atlanta, GA, 30303, USA.
Derek W TrobaughCenter for Vaccine Research, Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15261, USA.
William B KlimstraCenter for Vaccine Research, Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Lori A Emert-SedlakDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15219, USA.
Thomas E SmithgallDrug Discovery Institute, Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
Paul R KinchingtonDepartment of Ophthalmology, and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Stephen VadiaCenter for Microbial Interface Biology and Department of Microbial Infection and Immunity, Ohio State University, Columbus, OH 43210, USA.
Stephanie SeveauGeorgia State University, Biology Department, Atlanta, GA, 30303, USA.
Jon P BoyleDepartment of Biological Sciences, Dietrich School of Arts and Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Carolyn B Coyne *Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15219, USA.
Yoel Sadovsky *Magee-Womens Research Institute, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA 15213, USA.
University of Pittsburgh · USGeorgia State University · USInterface (United States) · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Virus Production and Manipulation of Protein/Gene Expression ModuleP30EY008098 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Ethan A Rossi · 1989 to 2026
$17.8M
Viral Persistence and PathogenesisT32AI049820 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DELUCA, NEAL A. · 2001 to 2024
$5.5M
Immunology of Infectious DiseaseT32AI060525 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JoAnne L. Flynn · 2005 to 2026
$5.3M
Small Molecule Inhibitors of HIV Nef SignalingR01AI057083 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SMITHGALL, THOMAS E. · 2003 to 2019
$5.1M
Enterovirus Infection of Polarized Intestinal CellsR01AI081759 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COYNE, CAROLYN B · 2009 to 2024
$5.0M
Molecular Mechanisms of Eastern Equine Encephalitis Virus PathogenesisR01AI095436 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLIMSTRA, WILLIAM B · 2012 to 2022
$4.5M
Varicella zoster virus-Induced Pain in a Rat Model of Post-Herpetic NeuralgiaR01NS064022 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KINCHINGTON, PAUL R. · 2009 to 2019
$3.6M
Primary human trophoblasts and the transfer of viral resistanceR01HD075665 · NICHD · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI COYNE, CAROLYN B, SADOVSKY, YOEL · 2012 to 2016
$2.4M
Structural Biology of HIV-1 Nef with Host Effectors and Small Molecule InhibitorsR01AI102724 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALVARADO, JOHN JEFF, SMITHGALL, THOMAS E. · 2013 to 2017
$1.9M
Multifaceted activity of listeriolysin O during host cell invasion by ListeriaR01AI107250 · NIAID · OHIO STATE UNIVERSITY · PI SEVEAU, STEPHANIE M M · 2014 to 2018
$1.9M
Placental injury and microRNAR01HD065893 · NICHD · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI SADOVSKY, YOEL · 2010 to 2014
$1.5M
NCATS NIH HHS UL1 TR000005NEI NIH HHS P30 EY008098NEI NIH HHS P30EY08098NIAID NIH HHS R01 AI057083NIAID NIH HHS R01AI057083NIAID NIH HHS R01 AI081759NIAID NIH HHS R01AI081759NIAID NIH HHS R01 AI083383NIAID NIH HHS R01AI083383NIAID NIH HHS R01 AI095436NIAID NIH HHS R01 AI102724NIAID NIH HHS R01 AI107250NIAID NIH HHS R21 AI093906NIAID NIH HHS R21AI093906NIAID NIH HHS R21 AI105588NIAID NIH HHS T32 AI049820NIAID NIH HHS T32AI049820NIAID NIH HHS T32 AI060525NIAID NIH HHS T32AI060525NICHD NIH HHS R01 HD065893NICHD NIH HHS R01HD065893NICHD NIH HHS R01 HD075665NICHD NIH HHS R01HD075665NICHD NIH HHS R21 HD071707NICHD NIH HHS R21HD071707NINDS NIH HHS R01 NS064022NINDS NIH HHS R01NS064022
6 · The paper itself

Abstract

objectivePrimary human trophoblasts were previously shown to be resistant to viral infection, and able to confer this resistance to nontrophoblast cells. Can trophoblasts protect nontrophoblastic cells from infection by viruses or other intracellular pathogens that are implicated in perinatal infection? STUDY

designIsolated primary term human trophoblasts were cultured for 48-72 hours. Diverse nonplacental human cell lines (U2OS, human foreskin fibroblast, TZM-bl, MeWo, and Caco-2) were preexposed to either trophoblast conditioned medium, nonconditioned medium, or miR-517-3p for 24 hours. Cells were infected with several viral and nonviral pathogens known to be associated with perinatal infections. Cellular infection was defined and quantified by plaque assays, luciferase assays, microscopy, and/or colonization assays. Differences in infection were assessed by Student t test or analysis of variance with Bonferroni correction.

resultsInfection by rubella and other togaviruses, human immunodeficiency virus-1, and varicella zoster was attenuated in cells preexposed to trophoblast-conditioned medium (P < .05), and a partial effect by the chromosome 19 microRNA miR-517-3p on specific pathogens. The conditioned medium had no effect on infection by Toxoplasma gondii or Listeria monocytogenes.

conclusionOur findings indicate that medium conditioned by primary human trophoblasts attenuates viral infection in nontrophoblastic cells. Our data point to a trophoblast-specific antiviral effect that may be exploited therapeutically.

Indexed as

Disease ResistanceCells, CulturedCulture Media, ConditionedFetal DiseasesHumansInfant, NewbornTrophoblastsVirus DiseasesCulture Media, Conditionedchromosome 19 microRNA clusterconditioned mediummicroRNAtrophoblastsviruses

Identifiers

PMID25108145
PMCPMC4275367
OpenAlexW2022250968

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.